TELO vs TTWO · $86.0M cap vs rev $6.66B
Telomir Pharmaceuticals, Inc. Common Stock (TELO) versus Take-Two Interactive Software Inc (TTWO) — a side-by-side from cached financials, not a winner call.
Telomir Pharmaceuticals, Inc. Common Stock (TELO) is a biotechnology company listed on NASDAQ.
Take-Two Interactive Software Inc (TTWO) is a electronic gaming & multimedia company listed on NASDAQ.
TELO does not have a complete income-statement cache yet.
Latest reported TTWO revenue for 2026-03-31 was $6.66B. Net income was -$298.2M. Revenue was up 18.2% from 2025-03-31 to 2026-03-31. TTWO currently screens at market cap $42.34B.
TELO currently screens at market cap $86.0M. TTWO currently screens at market cap $42.34B.
Not investment advice. Open the TELO and TTWO stock pages for the full models.
Not investment advice.